Quick Takeaways
- Muneer A. Satter filed SCHEDULE 13G/A for Akebia Therapeutics, Inc. Common Stock, par value $0.00001 (AKBA).
- Disclosed ownership: 2.6%.
- Date of event: 31 Dec 2024.
Muneer A. Satter - 31 Dec 2024 SCHEDULE 13G/A Report for Akebia Therapeutics, Inc. Common Stock, par value $0.00001 (AKBA)
- Filing Manager
- Muneer A. Satter
- Reporting Manager
- Satter Muneer A
- Symbol
- AKBA
- Shares outstanding
- 221,073,308 shares
- Disclosed Ownership
- 5,747,906 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 17:00:44 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Muneer A. Satter disclosed 2.6% ownership in Akebia Therapeutics, Inc. Common Stock, par value $0.00001 (AKBA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Satter Muneer A | 2.6% | 5,747,906 | 5,747,906 | 0 | /s/ Muneer A. Satter | Satter Muneer A |